EDBI Pte Ltd’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

EDBI Pte Ltd’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-427,070	Closed	-$109K	–	21
2023 Q1	$109K	Hold	427,070	–	–	0.12%	19
2022 Q4	$504K	Hold	427,070	–	–	0.64%	14
2022 Q3	$871K	Hold	427,070	–	–	0.92%	15
2022 Q2	$658K	Hold	427,070	–	–	0.61%	14
2022 Q1	$2.16M	Buy	427,070 +699	+0.2%	+$3.18K	1.44%	14
2021 Q4	$2.64M	Buy	+426,371	New	+$3.81M	1.44%	12

EDBI Pte Ltd's PEAR Position: Q2 2023 in Review

EDBI Pte Ltd sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 427,070 shares — an estimated $109K sold.

EDBI Pte Ltd first reported a position in PEAR in Q4 2021 and held it in 6 quarters. The position peaked at $2.64M in Q4 2021. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

EDBI Pte Ltd reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
EDBI Pte Ltd sold 427,070 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $109K.
EDBI Pte Ltd first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
EDBI Pte Ltd's Pear Therapeutics, Inc. Class A Common Stock position peaked at $2.64M in Q4 2021.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on EDBI Pte Ltd's 13F filing for Q2 2023, filed 2 Aug 2023.